GlassScriptPhysician profile
Christopher J Moshoures
NPI 1770537268
$4,675.30
in general payments reported to CMS, 2019-2025
21 companies · $965 in 2025
The $965 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $275 · 2021: $632 · 2022: $305 · 2023: $996 · 2024: $1,126 · 2025: $965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,087.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $926.99 | 2019-2025 | Precision7, Total30, Rhopressa |
| Coopervision INC. | $797.41 | 2019-2024 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $769.63 | 2023-2025 | Infuse, Biotrue, Envista Aspire Iol |
| Johnson & Johnson Vision Care, INC. | $484.44 | 2019-2025 | Acuvue |
| Biotissue Holdings INC. | $387.54 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $292.25 | 2019-2025 | Cequa |
| Optos, INC. | $256.94 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $139.40 | 2025 | Xdemvy |
| Oyster Point Pharma, INC. | $128.92 | 2023-2025 | Tyrvaya, Ryzumvi |
| New World Medical,INC. | $124.24 | 2023 | |
| Dompe US, INC. | $105.43 | 2024-2025 | Oxervate |
| Carl Zeiss Meditec USA, INC. | $45.00 | 2021-2023 | Cirrus Hd-Oct |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $38.43 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $32.64 | 2020 | |
| Harrow Eye, LLC | $28.68 | 2025 | Vevye |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Notal Vision, INC. | $23.66 | 2024 | Foresee Home |
| Abbvie INC. | $20.54 | 2022 | |
| Abb Con-Cise Optical Group LLC | $19.77 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Mallinckrodt Hospital Products INC. | $18.07 | 2022 | |
| Shire North American Group INC | $15.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Moshoures listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.